Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.60p -1.26% 46.90p 47.00p 48.50p 49.00p 43.75p 47.00p 2,189,083 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 96.00

Futura Medical Share Discussion Threads

Showing 16651 to 16674 of 17075 messages
Chat Pages: Latest  671  670  669  668  667  666  665  664  663  662  661  660  Older
DateSubjectAuthorDiscuss
07/3/2019
12:18
Not only is the product patented but we are awaiting news on further extensions to the patents.The second half of this year is going to get pretty exciting.Will likely all start with the UK regulatory approval for TPR100 the first pain gel.I would not be at all surprised when the share price quote is 150/155p instead of 15/15.5p.
j777j
07/3/2019
12:06
>9degreesThe patent protection prevents penetration FUM have a patent so others would have to licence from them.
xippy
07/3/2019
11:16
what are the barriers to entry of this product ??!! others will soon penetrate the market
9degrees
06/3/2019
13:15
What a load of tosh.You have no proof of that at all.
j777j
06/3/2019
13:02
It's not manipulation.It's Lombard Odier probably selling whenever there's any kind of bid in size.They won't stop.They have a remit I believe to exodus Aim stocks. Until another large buyer steps in, the share will tread water at best. If anyone else was running the company instead of Barder,I'm sure the shares would be much closer to a 100p than languishing at these paltry levels.
wantage
06/3/2019
12:48
Price should have another zero on it,If things go to plan..
j777j
06/3/2019
11:45
bioking you cannot oppose 30 odd million shares being dumped as soon as your ramping has got underway !
mikethebike4
06/3/2019
11:16
There cannot be a more volatile share on AIM.There is no news but we see 15% swings in the share price on a daily basis.This is MM manipulation and many get shafted!
martinelwick
06/3/2019
07:10
Market cap 27 million /Cash 10.5 million / Potency Drug with 2+ BILLION Market potential /CSD500 Condom approved in Europe and many Countries outside of Europa + more Approvals & Licensing deals coming / TPR100 (Topical Gel for Pain ) first approval expected next Quarter = POTENTIAL 10++ BAGGER GEM This new gel could give you an erection within 5 minutes, according to a study Apart from the fact that it works fast, there are a number of benefits from this new treatment for ED; one of them being the fact that it is a topical drug and is simpler than drugs like Viagra and Cialis. According to Dr Rajfar, who spoke to Men™s Health earlier, Viagra and Cialis work best on an empty stomach, requiring you to wait for two to three hours after consuming a large meal. You don™t have to worry about any of that with the gel and just get down and dirty after application. So, it might be smart for you to consider switching your treatment to this nitroglycerin gel which might get you laid faster than you can spell its name. Market potential The market for ED undoubtedly offers Futura a huge opportunity. Independent market research conducted on the company™s behalf indicates MED2005 could generate potentially $1bn (£781m) in annual sales from both prescription and over-the-counter sales priced at $5 £3.90 per dose. The prescription market alone was worth over $5.6bn in 2016. The profit margin on the product, which will have patent protection, is massive, too, as the cost is expected to be under ‚¬0.30 per dose (26.5p). Extensive work is being carried out to produce the chemistry, manufacturing and controls package required for regulatory submission and to establish the supply chain. A huge addressable market and profit margin makes this a blue-sky opportunity.
bioking
05/3/2019
20:30
Futura Medical will announce its preliminary results for the year ended 31 December 2018 on Wednesday 10 April 2019!!! I say yeah!
ih_635590
05/3/2019
11:56
Logically bangs up at such a low rating !!!
ih_635590
05/3/2019
11:07
send more emails to large pharmas like TEVA ,Allergan and Novartis to look into this one maybe it fits with their product pipeline ..FUM is a super attractive takeover target because of its terrible low valuation of 26 million
bioking
05/3/2019
10:11
20p+++++ this week...good news comingggggggggggggg
bioking
05/3/2019
08:59
partnership or buyout in the making =100p coming ralllyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyy
bioking
05/3/2019
07:55
Onwards & upwards here, (MSYS) should be in focus too, along with (STX) & (BLU) Certainly seeing some of these tiddlers taking off now.
ny boy
05/3/2019
06:57
valuation of 27 Million for this BEST POTENCY DRUG OUT THERE is unbelievable companies who developed the big Blockbuster like Cialis and Viagra quickly add BILLIONS OF DOLLARS TO THEIR VALUE and we have the wayyy better ED DRUG here than those blockbusters. And FUM has another Products to be launched soon alone these products will push the company into profitability .STRONG BUY TGT £2+ This new gel could give you an erection within 5 minutes, according to a study Apart from the fact that it works fast, there are a number of benefits from this new treatment for ED; one of them being the fact that it is a topical drug and is simpler than drugs like Viagra and Cialis. According to Dr Rajfar, who spoke to Men™s Health earlier, Viagra and Cialis work best on an empty stomach, requiring you to wait for two to three hours after consuming a large meal. You don™t have to worry about any of that with the gel and just get down and dirty after application. So, it might be smart for you to consider switching your treatment to this nitroglycerin gel which might get you laid faster than you can spell its name. Market potential The market for ED undoubtedly offers Futura a huge opportunity. Independent market research conducted on the company™s behalf indicates MED2005 could generate potentially $1bn (£781m) in annual sales from both prescription and over-the-counter sales priced at $5 £3.90 per dose. The prescription market alone was worth over $5.6bn in 2016. The profit margin on the product, which will have patent protection, is massive, too, as the cost is expected to be under ‚¬0.30 per dose (26.5p). Extensive work is being carried out to produce the chemistry, manufacturing and controls package required for regulatory submission and to establish the supply chain. A huge addressable market and profit margin makes this a blue-sky opportunity.
bioking
05/3/2019
01:52
Any sense left this thread a while ago. Now it's just borking.
glavey
04/3/2019
23:28
i know its double blind and im not talking about efficacy but more about safety profile of those higher doses so no bad news so far is good news . and regarding ramping do you really think that people buying this stock just because of my postings without doing their own research ? i never bought a single stock in last 20 years without doing my dd .who the hell would blind buy a stock just because someone is pumping it ?????????
bioking
04/3/2019
22:07
5187 phase 3 ongoing for 5 months now may be they like whatthey seeso far ....tgt 100p++ KAAAAAAAAAAAAAAAAAAABOOOOOOOOOOOOOOOOOOOOOM Its a double blind study, they will not know any results until completion, 'headline' efficacy results are not expected until December 2019 (Futura Medical Website) Bioking, you are a dangerous ramper, who knows nothing about how clinical trials are run or how the pharmaceutical industry works in general, you are just trying to draw people in so you can make another quick profit at their loss!
gadolinium
04/3/2019
19:08
Lombard still holding a massive stake of 36 million shares , stock went up 200% me self sold about 50% of my stake at 20p and bought the shares back at 12p .Who in the hell wouldnt sell after a quick 200% jump ?
bioking
04/3/2019
17:19
100p ????? Wake me up when it happens.Lombard Odier seem to be very happy selling stock at around 20P.It seems no other institution wants to take out their stake.
wantage
04/3/2019
11:07
looks like big news on the way like partnershipor maybe buyout , phase 3 ongoing for 5 months now may be they like whatthey seeso far ....tgt 100p++ KAAAAAAAAAAAAAAAAAAABOOOOOOOOOOOOOOOOOOOOOM
bioking
04/3/2019
10:13
Market cap 27 million /Cash 10.5 million / Potency Drug with 2 BILLION Market potential /CSD500 Condom approved in Europe and many Countries outside of Europa + more Approvals & Licensing deals coming / TPR100 (Topical Gel for Pain ) first approval expected next Quarter = POTENTIAL 10++ BAGGER GEM RALLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY Market potential The market for ED undoubtedly offers Futura a huge opportunity. Independent market research conducted on the company™s behalf indicates MED2005 could generate potentially $1bn (£781m) in annual sales from both prescription and over-the-counter sales priced at $5 (£3.90) per dose. The prescription market alone was worth over $5.6bn in 2016. The profit margin on the product, which will have patent protection, is massive, too, as the cost is expected to be under ‚¬0.30 per dose (26.5p). Extensive work is being carried out to produce the chemistry, manufacturing and controls package required for regulatory submission and to establish the supply chain. A huge addressable market and profit margin makes this a blue-sky opportunity.
bioking
04/3/2019
09:11
upfront payment alone will be higher than current laughable valuation on 27 million in the case of a partnership this shows how massive underpriced the stock is .
bioking
Chat Pages: Latest  671  670  669  668  667  666  665  664  663  662  661  660  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190717 16:27:07